Kiromic BioPharma Inc

NASDAQ:KRBP   3:55:44 PM EDT
0.39
-0.04 (-8.26%)
Products

Kiromic Biopharma Expands Gamma Delta T Cell Product Pipeline With New Sponsored Research Agreement

Published: 06/07/2022 11:20 GMT
Kiromic BioPharma Inc (KRBP) - Kiromic Biopharma Significantly Expands Gamma Delta T Cell Product Pipeline With New Sponsored Research Agreement.
Kiromic Biopharma - Under Two-year Sra, in Vivo Preclinical Data Will Be Generated From Kiromic's Gamma Delta T Cell (gdt) Allogeneic Therapies.
Kiromic Biopharma - Sra Intended to Evaluate Efficacy and Patient Safety Outcomes to Support Three New Investigational Drug (ind) Applications to FDA.